drugset / Trial / NCT01190371
Have Malaria Infections in Kenya Become Less Responsive to Artemisinin Treatment?
Phase 4
Unknown
175 enrolled
KEMRI-Wellcome Trust Collaborative Research Program
Heidelberg University · collabUniversity of Oxford · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether P. falciparum infections in Kilifi District have developed tolerance to the artemisinin class of drugs.
Timeline
- Start
- 2011-04
- Primary completion
- 2011-11
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | 2 mg/kg | Oral |